Comments on: PARP inhibitors arrive in China via new priority review pathway /comment/parp-inhibitors-china/ The leading site for news and procurement in the pharmaceutical industry Wed, 27 Oct 2021 12:54:55 +0000 hourly 1 https://wordpress.org/?v=6.7.2